Holger Bronger

2.0k total citations
46 papers, 1.2k citations indexed

About

Holger Bronger is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Holger Bronger has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 13 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Holger Bronger's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers), Ovarian cancer diagnosis and treatment (9 papers) and Chemokine receptors and signaling (8 papers). Holger Bronger is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers), Ovarian cancer diagnosis and treatment (9 papers) and Chemokine receptors and signaling (8 papers). Holger Bronger collaborates with scholars based in Germany, United States and Austria. Holger Bronger's co-authors include Marion Kiechle, Stefanie Avril, Manfred Schmitt, Barbara Schmalfeldt, Tobias Dreyer, Rezvan Ahmadi, Hans‐Herbert Steiner, Kathrin Kopplow, Christel Herold‐Mende and Jörg König and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Holger Bronger

44 papers receiving 1.2k citations

Peers

Countries citing papers authored by Holger Bronger

Since Specialization

Citations

This map shows the geographic impact of Holger Bronger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Bronger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Bronger more than expected).

Fields of papers citing papers by Holger Bronger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Bronger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Bronger. The network helps show where Holger Bronger may publish in the future.

Co-authorship network of co-authors of Holger Bronger

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Bronger. A scholar is included among the top collaborators of Holger Bronger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Bronger. Holger Bronger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Large language models-enabled digital twins for precision medicine in rare gynecological tumors 2025 ·npj Digital Medicine ·(unknown), Nicole Pfarr, (unknown), (unknown), Tobias Dreyer, (unknown), Patrick Metzger, Dyke Ferber, Jakob Nikolas Kather, Daniel Truhn, Lisa C. Adams, Keno K. Bressem, Sebastian Lange, Kristina Schwamborn, Martin Boeker, Marion Kiechle, Ulrich A. Schatz, Holger Bronger, (unknown)	4
2	The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer 2025 ·Neoplasia ·Stefanie Seitz, Tobias Dreyer, (unknown), Katja Steiger, Dirk Wohlleber, Martina Anton, (unknown), (unknown), Ute Reuning, Gabriele Multhoff, Wilko Weichert, Marion Kiechle, Viktor Magdolen, Holger Bronger	1
3	Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients 2023 ·Cancers ·Fabian Stögbauer, (unknown), Christine Brambs, (unknown), Tim Kacprowski, (unknown), Holger Bronger, Marion Kiechle, Aurelia Noske, Gisela Keller, Moritz Jesinghaus, Christopher Poremba, Wilko Weichert, Melanie Boxberg	1
4	Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancer. 2023 ·PubMed ·Yueyang Liu, (unknown), Konstantina Panoutsopoulou, Thirza Singer‐Cornelius, (unknown), Holger Bronger, Marion Kiechle, Julia Dorn, Andreas Scorilas, Margaritis Avgeris, Viktor Magdolen, Tobias Dreyer	6
5	2022-RA-800-ESGO AGO-OVAR 27: window-of-opportunity proof-of-concept, non-randomized, open-label phase ii trial of olaparib given alone or in combination with durvalumab prior to primary debulking surgery in histologically proven high-grade epithelial ovarian cancer 2022 ·International Journal of Gynecological Cancer ·Frederik Marmé, Florian Heitz, Philipp Harter, Alexander Reuß, (unknown), Pauline Wimberger, Holger Bronger, Andreas du Bois, (unknown), Felix Hilpert	1
6	CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer 2022 ·British Journal of Cancer ·(unknown), Tobias Dreyer, (unknown), Katja Steiger, (unknown), (unknown), Gabriele Multhoff, Wilko Weichert, Marion Kiechle, Viktor Magdolen, Holger Bronger	42
7	Platelet mitochondrial membrane depolarization reflects disease severity in patients with preeclampsia 2022 ·Molecular Medicine ·Bjoern F. Kraemer, (unknown), (unknown), (unknown), Tobias Dreyer, Marion Kiechle, Bettina Kuschel, Holger Bronger	8
8	Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer 2020 ·Journal of Ovarian Research ·Weiwei Gong, Yueyang Liu, Eleftherios P. Diamandis, Marion Kiechle, Holger Bronger, Julia Dorn, Tobias Dreyer, Viktor Magdolen	7
9	Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients 2019 ·PLoS ONE ·Weiwei Gong, Yueyang Liu, Christof Seidl, Tobias Dreyer, Enken Drecoll, Matthias Kotzsch, Holger Bronger, Julia Dorn, Viktor Magdolen	12
10	Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors 2019 ·Cancer and Metastasis Reviews ·Holger Bronger, Viktor Magdolen, Peter Goettig, Tobias Dreyer	27
11	CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patients 2017 ·Oncogenesis ·(unknown), (unknown), Stefanie Avril, Melanie Boxberg, (unknown), Barbara Schmalfeldt, Manfred Schmitt, Marion Kiechle, Holger Bronger	26
12	MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer 2017 ·Breast Cancer Research and Treatment ·(unknown), Holger Bronger, (unknown), Marion Kiechle, Wilko Weichert, Stefanie Avril	48
13	Induction of cathepsin B by the CXCR3 chemokines CXCL9 and CXCL10 in human breast cancer cells 2017 ·Oncology Letters ·Holger Bronger, (unknown), Tobias Dreyer, (unknown), (unknown), Stefanie Avril, Marion Kiechle, Manfred Schmitt	33
14	Sarcopenia in Advanced Serous Ovarian Cancer 2016 ·International Journal of Gynecological Cancer ·Holger Bronger, (unknown), Alexander Hapfelmeier, Stephan Metz, Peter B. Noël, Marion Kiechle, Barbara Schmalfeldt	53
15	Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping 2012 ·Clinical Cancer Research ·Julia Wulfkuhle, Daniela Berg, Claudia Wolff, Rupert Langer, (unknown), Julie Illi, Virginia Espina, Mariaelena Pierobon, Jianghong Deng, Angela DeMichele, Axel Walch, Holger Bronger, Ingrid Becker, (unknown), Heinz Höfler, Laura J. Esserman, (unknown), Lance A. Liotta, Karl‐Friedrich Becker, Emanuel F. Petricoin	85
16	uPA and PAI-1-Related Signaling Pathways Differ between Primary Breast Cancers and Lymph Node Metastases 2012 ·Translational Oncology ·Katharina Malinowsky, Claudia Wolff, Daniela Berg, Tibor Schuster, Axel Walch, Holger Bronger, Heiko Mannsperger, Christian Schmidt, Ulrike Korf, Heinz Höfler, Karl‐Friedrich Becker	28
17	Intratumoral Heterogeneity of MicroRNA Expression in Breast Cancer 2012 ·Journal of Molecular Diagnostics ·(unknown), Tibor Schuster, (unknown), Katharina Malinowsky, Holger Bronger, Ulrike Schwarz‐Boeger, Heinz Höfler, Stefanie Avril	37
18	Development of endothelium-denuded human umbilical veins as living scaffolds for tissue-engineered small-calibre vascular grafts 2012 ·Journal of Tissue Engineering and Regenerative Medicine ·Markus Hoenicka, (unknown), Jiří Burša, (unknown), Holger Bronger, Çhristof Schmid, Dietrich E. Birnbaum	14
19	Profiling signalling pathways in formalin‐fixed and paraffin‐embedded breast cancer tissues reveals cross‐talk between EGFR, HER2, HER3 and uPAR 2011 ·Journal of Cellular Physiology ·Daniela Berg, Claudia Wolff, Katharina Malinowsky, (unknown), Axel Walch, Holger Bronger, Tibor Schuster, Heinz Höfler, Karl‐Friedrich Becker	19
20	Signalling networks associated with urokinase‐type plasminogen activator (uPA) and its inhibitor PAI‐1 in breast cancer tissues: new insights from protein microarray analysis 2010 ·The Journal of Pathology ·Claudia Wolff, Katharina Malinowsky, Daniela Berg, (unknown), Tibor Schuster, Axel Walch, Holger Bronger, Heinz Höfler, Karl‐Friedrich Becker	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact